Viewing StudyNCT00499707



Ignite Creation Date: 2024-05-05 @ 6:31 PM
Last Modification Date: 2024-10-26 @ 9:34 AM
Study NCT ID: NCT00499707
Status: COMPLETED
Last Update Posted: 2018-03-21
First Post: 2007-07-09

Brief Title: Efficacy and Safety Study of RosiglitazoneMetformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Diabetes Mellitus Type 2
Keywords:
Name View
type 2 diabetes View
HbA1c View
Drug-naive View